VectorY Therapeutics

Alexander Vos – CEO
Alexander Vos – CEO
Netherlands | Funding: €160M (+)

Website: https://www.vectorytx.com/

VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.